0001786949-20-000001.txt : 20200626 0001786949-20-000001.hdr.sgml : 20200626 20200625202745 ACCESSION NUMBER: 0001786949-20-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200626 DATE AS OF CHANGE: 20200625 EFFECTIVENESS DATE: 20200626 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sparrow Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001786949 IRS NUMBER: 464189155 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-353578 FILM NUMBER: 20990702 BUSINESS ADDRESS: STREET 1: 4640 SW MACADAM AVE STREET 2: SUITE 270 CITY: PORTLAND STATE: OR ZIP: 97239 BUSINESS PHONE: 312-752-8446 MAIL ADDRESS: STREET 1: 4640 SW MACADAM AVE STREET 2: SUITE 270 CITY: PORTLAND STATE: OR ZIP: 97239 D/A 1 primary_doc.xml X0708 D/A LIVE 0001786949 Sparrow Pharmaceuticals, Inc. 920 SW 6th Ave Suite 1200 PORTLAND OR OREGON 97204 312-752-8446 DELAWARE None None Corporation true David Aaron Katz 2616 SE 35th Place Portland OR OREGON 97202 Executive Officer Director Pharmaceuticals No Revenues 06b true 0001786949-19-000001 2018-08-21 true true true false 10000 Exemplar Capital, LLC 155786 None None 10 Post Office Square 8th Floor South Boston MA MASSACHUSETTS 02101 IL ILLINOIS OR OREGON WA WASHINGTON false 337500 337500 0 This filing reflects in part the total amount raised under the self-issuance exemption. The Company later engaged a FINRA member, Exemplar Capital, to continue the offering as broker-dealer of record. The Company has now ended this offering. false 10 675 0 0 false Sparrow Pharmaceuticals, Inc. David Aaron Katz David Aaron Katz CEO 2020-06-25